Blog
RSS FeedPosted by Michael Wonder on 16 Sep 2017
Proposal to fund zoster vaccine
15 September 2017 - PHARMAC is seeking feedback on a proposal to fund the zoster vaccine (Zostavax) for the prevention ...
Posted by Michael Wonder on 11 Sep 2017
Iron infusions in the community
11 September 2017 - Eligible people will now be able to receive ferric carboxymaltose iron infusions in some general practitioners’ ...
Posted by Michael Wonder on 04 Sep 2017
Decision to award sole supply for nicotine replacement therapy
4 September 2017 - PHARMAC is pleased to announce the approval of an agreement with GSK for the supply of ...
Posted by Michael Wonder on 31 Aug 2017
New Zealand Pharmaceutical Schedule - 1 September 2017
1 September 2017 - The September 2017 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...
Posted by Michael Wonder on 31 Jul 2017
New Zealand Pharmaceutical Schedule - 1 August 2017
1 August 2017 - The August 2017 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...
Posted by Michael Wonder on 24 Jul 2017
Nicotine replacement therapy
21 July 2017 - PHARMAC proposes to continue to fund the Habitrol brand of nicotine gum, lozenges and patches supplied ...
Posted by Michael Wonder on 20 Jul 2017
Proposal to change aripiprazole access and brand
20 July 2017 - PHARMAC proposes two key changes to the funding of aripiprazole tablets, an antipsychotic medicine for use ...
Posted by Michael Wonder on 06 Jul 2017
Additional listings on the Pharmaceutical Schedule of a range of orthopaedic implants and associated products with Johnson & Johnson
6 July 2017 - PHARMAC is pleased to announce the approval of an amendment to the suture agreement with Johnson ...
Posted by Michael Wonder on 01 Jul 2017
New Zealand Pharmaceutical Schedule - 1 July 2017
1 July 2017 - The July 2017 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...
Posted by Michael Wonder on 21 Jun 2017
Agreement with ArjoHuntleigh Limited for the supply of medical devices used in the prevention of venous thromboembolism
21 June 2017 - PHARMAC is pleased to announce the approval of an agreement with ArjoHuntleigh for the supply of ...
Posted by Michael Wonder on 15 Jun 2017
Cancer patients, children, and people with HIV amongst those to benefit from PHARMAC decisions
15 June 2017 - PHARMAC has announced the funding of five new treatments and wider use of over 30 existing ...
Posted by Michael Wonder on 15 Jun 2017
Bendamustine funding approved
15 June 2017 - PHARMAC is pleased to announce the approval of an agreement with Janssen-Cilag for the listing of ...
Posted by Michael Wonder on 13 Jun 2017
Proposal to list a range of Interventional Cardiology products supplied by Edwards Lifesciences
13 June 2017 - PHARMAC is seeking feedback on a proposal to list a range of Interventional Cardiology products supplied ...
Posted by Michael Wonder on 12 Jun 2017
Changes to the National Immunisation Schedule - meningococcal C conjugate vaccine
12 June 2017 - PHARMAC is pleased to announce a decision related to the National Immunisation Schedule (NIS) that will ...
Posted by Michael Wonder on 12 Jun 2017
Proposal for various medicines in the neurology, immunology and nephrology therapeutic areas approved
12 June 2017 - PHARMAC is pleased to announce the approval of a proposal relating to certain medicines in the ...